Pankaj Patel was also the President of the Federation of Indian Chamber of Commerce & Industry (FICCI) (2016-17). He is also the Executive Chairman, Vice President and Trustee of the Gujarat Cancer Society and Chairman of the Gujarat Cancer and Research Institute.
The company had posted a consolidated net profit of Rs 679 crore in the same quarter of previous fiscal year, Zydus Lifesciences said in a regulatory filing.
The company has received final approval from the US Food and Drug Administration (USFDA) to Decitabine for Injection in the strength of 50 mg/vial single-dose vial, Zydus Cadila said in a statement.
The NDA received tentative approval upon completion of the first review cycle on September 2, 2021, Zydus Cadila stated.
The company's indigenously developed needle-free three-dose COVID-19 vaccine ZyCoV-D was granted emergency use authorisation (EUA) by the drug regulator on Friday, making it the first vaccine to be administered to beneficiaries in the age group of 12-18 years in the country.
Zydus Group MD Dr. Sharvil Patel has claimed that 'ZyCoV-D' vaccine holds about 66% efficacy against the Delta variant of COVID-19.
The Drugs Controller General of India (DCGI) on Friday gave approval for emergency-use authorization of Zydus Cadila's ZyCoV-D vaccine, the Union Ministry of Science and Technology said. The world’s first and India’s indigenously developed DNA-based vaccine for COVID-19 will be administered in humans including children and adults 12 years and above, the ministry said.
The Drugs Controller General of India (DCGI) on Friday gave approval for emergency-use authorization of Zydus Cadila's ZyCoV-D vaccine, the Union Ministry of Science and Technology said. The world’s first and India’s indigenously developed DNA-based vaccine for COVID-19 will be administered in humans including children and adults 12 years and above, the ministry said.
Top News
Latest News
